Shopping Cart
- Remove All
- Your shopping cart is currently empty
AZD-8529 is a highly selective, and orally bioavailable positive allosteric modulator of mGluR2 (EC50: 285 nM). It shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,780 | 1-2 weeks | |
50 mg | $2,320 | 1-2 weeks | |
100 mg | $3,520 | 1-2 weeks |
Description | AZD-8529 is a highly selective, and orally bioavailable positive allosteric modulator of mGluR2 (EC50: 285 nM). It shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes. |
Targets&IC50 | mGluR2:(EC50)285 nM |
In vitro | AZD-8529 enhances the activity of glutamate at mGluR2 (EC50: 195 nM) without inducing antagonist responses on mGluRs at 25 μM. |
In vivo | AZD-8529 (30 mg/kg; i.p.) decreases the increased extracellular dopamine induced by nicotine in accumbens shell of freely-moving rats. AZD-8529 (0.3-mg/kg, i.m.) reduces nicotine priming-induced and cue-induced reinstatement in squirrel monkeys. |
Molecular Weight | 487.47 |
Formula | C24H24F3N5O3 |
Cas No. | 1092453-15-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.